Q2 2022 Earnings Forecast for Magenta Therapeutics, Inc. Issued By B. Riley (NASDAQ:MGTA)

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) – Analysts at B. Riley reduced their Q2 2022 EPS estimates for Magenta Therapeutics in a research report issued to clients and investors on Tuesday, May 17th. B. Riley analyst K. Patel now anticipates that the company will post earnings per share of ($0.41) for the quarter, down […]

Related Keywords

Wellington ,New Zealand General ,New Zealand , ,Magenta Therapeutics Inc ,Walleye Capital ,Zacks Investment Research ,Wellington Management Group ,Renaissance Technologies ,Nasdaq ,Magenta Therapeutics ,Get Rating ,Management Group ,Track Capital ,Nasdaq Mgta ,Mgta ,Medical ,Earnings Estimates ,B Riley ,